It is a chemicals private limited company based in Punjagutta, Hyderabad,082, Telangana, India, established in 2004.
2004 | Punjagutta, Hyderabad,082, Telangana, India | Struck OffInnomorph Drugs Private Limited, a struck off private limited company, was established on 11 November 2004 in Punjagutta, Hyderabad,082, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239TG2004PTC044602. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Pavani Bommareddy (Director), Venkatram Reddy Pulagam (Director), Veera Venkata Siva Kumar Reddy Bommareddy (Director). Its latest AGM occurred on 28 April 2018, with the balance sheet filed on 31 March 2018. It is based at 6-3-883/5. Venkat Plaza.Punjagutta, Hyderabad,082 Punjagutta, Hyderabad,082, Punjagutta, Hyderabad,082, Telangana.
U24239TG2004PTC044602
044602
11 November 2004
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Innomorph Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pavani Bommareddy | Director | 11 Nov 2004 | Current |
| Venkatram Reddy Pulagam | Director | 01 Aug 2011 | Current |
| Veera Venkata Siva Kumar Reddy Bommareddy | Director | 11 Nov 2004 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Innomorph Drugs Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 34.09% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
In 2018, Innomorph Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Innomorph Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Innomorph Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innomorph Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Innomorph Drugs Private Limited last Annual general meeting of members was held on 28 Apr 2018 as per latest MCA records. was completed.
Innomorph Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was recorded as a recent event.
Venkatram Reddy Pulagam was appointed as a Director was appointed as a Director on 01 Aug 2011 & has been associated with this company since 14 years 4 months . was recorded as a recent event.
The activity Pavani Bommareddy was appointed as a Director was appointed as a Director on 11 Nov 2004 & has been associated with this company since 21 years 24 days . was completed.
Progress on Veera Venkata Siva Kumar Reddy Bommareddy was appointed as a Director was appointed as a Director on 11 Nov 2004 & has been associated with this company since 21 years 24 days . was documented.
Progress on Innomorph Drugs Private Limited was registered on 11 Nov 2004 with Roc Hyderabad & aged 21 years 24 days as per MCA records. was documented.
The CIN of Innomorph Drugs Private Limited is U24239TG2004PTC044602.
Innomorph Drugs Private Limited is headquartered at 6-3-883/5. Venkat Plaza.Punjagutta, Hyderabad,082 Punjagutta, Hyderabad,082, Punjagutta, Hyderabad,082, Telangana.
Innomorph Drugs Private Limited was incorporated on 11 November 2004.
The current directors of Innomorph Drugs Private Limited are
The primary industry of Innomorph Drugs Private Limited is Chemicals.
Innomorph Drugs Private Limited is unlisted.
The authorized capital of Innomorph Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX